ep0042, an inhibitor of flt3 & aurora kinases, in r/r aml and mds: insights from a phase i/iia trial
Published 7 months ago • 127 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
2:44
phase i/ii study of novel flt3 inhibitor hm43239 in r/r aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
20:30
nanocharacterisation facility at inl
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
3:39
anbio af-100 single-channel bench-top fia analyzer
-
2:35
quizartinib for frontline flt3-itd aml: updated results from the quantum-first trial
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
3:04
ff-10101-01: a novel flt3 inhibitor for r/r aml
-
1:40
second-generation flt3 inhibitors in the treatment of flt3-itd aml
-
3:42
further analysis of quantum-first: the impact of allo-hct combined with quizartinib in flt3-itd aml
-
3:20
safety run-in of a phase ii trial of cpx-351 plus pomalidomide in aml with mds-related changes
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
3:03
quantum-first: flt3-itd-specific mrd to assess benefits of quizartinib in flt3-itd aml
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
2:54
quantum-first: association between flt3-itd-specific mrd clearance and survival in patients with aml
-
1:55
assessing flt3-itd-specific mrd clearance using a pcr-ngs assay in the quantum-first trial